Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

XOMA Royalty (XOMA) EBITDA (2016 - 2025)

Historic EBITDA for Royalty (XOMA) over the last 10 years, with Q3 2025 value amounting to -$1.3 million.

  • Royalty's EBITDA rose 9150.73% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 10690.15%. This contributed to the annual value of -$40.0 million for FY2024, which is 209.4% up from last year.
  • Latest data reveals that Royalty reported EBITDA of -$1.3 million as of Q3 2025, which was up 9150.73% from $4.6 million recorded in Q2 2025.
  • In the past 5 years, Royalty's EBITDA registered a high of $29.8 million during Q4 2021, and its lowest value of -$20.1 million during Q4 2023.
  • For the 5-year period, Royalty's EBITDA averaged around -$2.5 million, with its median value being -$4.7 million (2022).
  • Per our database at Business Quant, Royalty's EBITDA plummeted by 33039.47% in 2023 and then surged by 39601.85% in 2024.
  • Royalty's EBITDA (Quarter) stood at $29.8 million in 2021, then tumbled by 120.02% to -$6.0 million in 2022, then crashed by 236.5% to -$20.1 million in 2023, then skyrocketed by 63.93% to -$7.3 million in 2024, then surged by 81.69% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, $4.6 million for Q2 2025, and $5.9 million during Q1 2025.